Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1982-4-22
|
pubmed:abstractText |
Oral single dose kinetics of mefloquine was investigated in 16 male volunteers, 3 Caucasians and 13 African natives. Unchanged mefloquine (= M) and one of its metabolites (= MM) were measured in the plasma. The apparent half-life of absorption of M ranged from 0.36 to 2.0 h, its terminal half-life of elimination from 15 to 33 days. Assuming complete systemic availability, an apparent volume of distribution of 14-29 liters x kg-1 and a total clearance of 18-39 ml x min-1 were derived. MM given orally to mice or rats showed at equal dose the same tolerance as mefloquine. Following oral administration of M to man, plasma levels of MM surpassed those of M, resulting in a 2.4-5.1 larger AUC. However, because of its much smaller apparent volume of distribution, MM may be anticipated to represent only a small percentage of the dose and therefore to contribute only to a minor extent towards the unwanted side effects of the drug.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-3157
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
70-84
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:6976886-Adult,
pubmed-meshheading:6976886-Biotransformation,
pubmed-meshheading:6976886-Blood Proteins,
pubmed-meshheading:6976886-Erythrocytes,
pubmed-meshheading:6976886-Humans,
pubmed-meshheading:6976886-Intestinal Absorption,
pubmed-meshheading:6976886-Male,
pubmed-meshheading:6976886-Mefloquine,
pubmed-meshheading:6976886-Middle Aged,
pubmed-meshheading:6976886-Piperidines,
pubmed-meshheading:6976886-Protein Binding,
pubmed-meshheading:6976886-Quinolines,
pubmed-meshheading:6976886-Time Factors
|
pubmed:year |
1982
|
pubmed:articleTitle |
Single dose kinetics of mefloquine in man. Plasma levels of the unchanged drug and of one of its metabolites.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|